# Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption

> **NCT00235573** · NA · COMPLETED · sponsor: **University of Florida** · enrollment: 21 (actual)

## Conditions studied

- Disorder of Vitamin B12

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin B12

## Key facts

- **NCT ID:** NCT00235573
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2011-12-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00235573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00235573, "Evaluation of Holotranscobalamin as an Indicator of Vitamin B12 Absorption". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT00235573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*